1. Briakinumab for Treatment of Crohn's Disease: Results of a Randomized Trial. Issue 6 (June 2015) Authors: Panaccione, Remo; Sandborn, William J.; Gordon, Glenn L.; Lee, Scott D.; Safdi, Alan; Sedghi, Shahriar; Feagan, Brian G.; Hanauer, Stephen; Reinisch, Walter; Valentine, John F.; Huang, Bidan; Carcereri, Roberto Journal: Inflammatory bowel diseases Issue: Volume 21:Issue 6(2015:Jun.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Once-daily Mesalamine Formulation for Maintenance of Remission in Ulcerative Colitis: A Randomized, Placebo-controlled Clinical Trial. Issue 4 (April 2016) Authors: Gordon, Glenn L.; Zakko, Salam; Murthy, Uma; Sedghi, Shahriar; Pruitt, Ronald; Barrett, Andrew C.; Bortey, Enoch; Paterson, Craig; Forbes, William P.; Lichtenstein, Gary R. Journal: Journal of clinical gastroenterology Issue: Volume 50:Issue 4(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Once-daily mesalamine granules for maintaining remission of ulcerative colitis: pooled analysis of efficacy, safety, and prognostic factors. Issue 3 (2nd April 2016) Authors: Zakko, Salam F.; Gordon, Glenn L.; Murthy, Uma; Sedghi, Shahriar; Pruitt, Ronald; Barrett, Andrew C.; Bortey, Enoch; Paterson, Craig; Forbes, William P.; Lichtenstein, Gary R. Journal: Postgraduate medicine Issue: Volume 128:Issue 3(2016) Page Start: 273 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗